Biomimetic hydroxyapatite as potential polymeric nanocarrier for the treatment of rheumatoid arthritis

被引:19
作者
Ain, Quratul [1 ]
Zeeshan, Mahira [1 ]
Khan, Salman [1 ]
Ali, Hussain [1 ]
机构
[1] Quaid I Azam Univ, Dept Pharm, Islamabad 45320, Pakistan
关键词
bone remodeling; hydroxyapatite; polymeric nanocarriers; rheumatoid arthritis; targeted drug delivery; IN-VITRO; NANOPARTICLES; DELIVERY; NANOMEDICINE; PATHOGENESIS; BIOACTIVITY; IBUPROFEN;
D O I
10.1002/jbm.a.36765
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Rheumatoid arthritis (RA) is a chronic autoimmune disease of unknown etiology with much higher prevalence in world's population. RA is initially associated with inflammation of joints and cartilages that ultimately leads to their destruction thus requiring a therapeutic intervention. The available conventional therapeutic strategies for RA are not satisfactory because of the associated side effects such as toxicity, delayed action, and dependence. Therefore, a carrier system is required that should deliver the drug to the target site with minimal side effects. In this connection, nanocarrier systems are of prime importance because of the associated benefits such as their nano-scaled size, targeted drug delivery, and reduced toxicity that can improve the patient's compliance. Moreover, in the past few decades, nano-particulate-based drug delivery approaches that have been investigated for the treatment of RA include ceramics, polymers, and hydrogels. Among these nanocarrier systems, ceramics like hydroxyapatite have gathered striking attention due to their bioactive, biocompatible, and bio-conductive characteristics. Nano-sized hydroxyapatite (HA) permeates the bone tissues and serves as a source of calcium phosphates required for bone repairing that are damaged during disease process. The aim of this review article is to highlight the potential use of HA as nanocarrier for anti-rheumatic drugs as well its possible effect on bone remodeling.
引用
收藏
页码:2595 / 2600
页数:6
相关论文
共 35 条
[21]  
Nabipour Z., 2018, IRANIAN J PHARM SCI, V14, P75, DOI DOI 10.22034/IJPS.2018.32051
[22]   Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis [J].
Nissen, Steven E. ;
Yeomans, Neville D. ;
Solomon, Daniel H. ;
Luescher, Thomas F. ;
Libby, Peter ;
Husni, M. Elaine ;
Graham, David Y. ;
Borer, Jeffrey S. ;
Wisniewski, Lisa M. ;
Wolski, Katherine E. ;
Wang, Qiuqing ;
Menon, Venu ;
Ruschitzka, Frank ;
Gaffney, Michael ;
Beckerman, Bruce ;
Berger, Manuela F. ;
Bao, Weihang ;
Lincoff, A. Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (26) :2519-2529
[23]  
Ong JL, 2000, CRIT REV BIOMED ENG, V28, p667A
[24]   Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations [J].
Pandey, Shweta ;
Kumar, Vijay ;
Leekha, Ankita ;
Rai, Nishant ;
Ahmad, Farhan Jalees ;
Verma, Anita Kamra ;
Talegaonkar, Sushama .
PHARMACEUTICAL RESEARCH, 2018, 35 (11)
[25]  
Prasad LK, 2015, NANOMEDICINE-UK, V10, P2063, DOI [10.2217/NNM.15.45, 10.2217/nnm.15.45]
[26]   Nanomedicines for Inflammatory Arthritis: Head-to-Head Comparison of Glucocorticoid-Containing Polymers, Micelles, and Liposomes [J].
Quan, Lingdong ;
Zhang, Yijia ;
Crielaard, Bart J. ;
Dusad, Anand ;
Lele, Subodh M. ;
Rijcken, Cristianne J. F. ;
Metselaar, Josbert M. ;
Kostkova, Hana ;
Etrych, Tomas ;
Ulbrich, Karel ;
Kiessling, Fabian ;
Mikuls, Ted R. ;
Hennink, Wim E. ;
Storm, Gert ;
Lammers, Twan ;
Wang, Dong .
ACS NANO, 2014, 8 (01) :458-466
[27]   Mechanism of Hydrogen-Bonded Complex Formation between Ibuprofen and Nanocrystalline Hydroxyapatite [J].
Ryabenkova, Yulia ;
Jadav, Niten ;
Conte, Marco ;
Hippler, Michael F. A. ;
Reeves-McLaren, Nik ;
Coates, Phil D. ;
Twigg, Peter ;
Paradkar, Anant .
LANGMUIR, 2017, 33 (12) :2965-2976
[28]   Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells [J].
Shi, Zhongli ;
Huang, Xin ;
Cai, Yurong ;
Tang, Ruikang ;
Yang, Disheng .
ACTA BIOMATERIALIA, 2009, 5 (01) :338-345
[29]   Biodegradable polymeric nanoparticles as drug delivery devices [J].
Soppimath, KS ;
Aminabhavi, TM ;
Kulkarni, AR ;
Rudzinski, WE .
JOURNAL OF CONTROLLED RELEASE, 2001, 70 (1-2) :1-20
[30]   MRI-assessed therapeutic effects of locally administered PLGA nanoparticles loaded with anti-inflammatory siRNA in a murine arthritis model [J].
te Boekhorst, Bernard C. M. ;
Jensen, Linda B. ;
Colombo, Stefano ;
Varkouhi, Amir K. ;
Schiffelers, Raymond M. ;
Lammers, Twan ;
Storm, Gert ;
Nielsen, Hanne M. ;
Strijkers, Gustav J. ;
Foged, Camilla ;
Nicolay, Klaas .
JOURNAL OF CONTROLLED RELEASE, 2012, 161 (03) :772-780